$50.43
-0.18-0.36%
At Close: -
$50.43
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | IONS | Ionis Pharmaceuticals | FY | 2024 | — | — | — | $575.00M | — | $618.12M | Get Alert |
02/21/2024 | IONS | Ionis Pharmaceuticals | FY | 2024 | — | — | — | $575.00M | — | $636.36M | Get Alert |
11/02/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $620.05M | Get Alert |
08/09/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $586.28M | Get Alert |
05/03/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $597.65M | Get Alert |
02/22/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $672.18M | Get Alert |
11/09/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $594.45M | Get Alert |
08/09/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $610.05M | Get Alert |
05/04/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $612.37M | Get Alert |
02/24/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $648.72M | Get Alert |
08/04/2021 | IONS | Ionis Pharmaceuticals | FY | 2021 | — | — | — | $600.00M | — | $618.55M | Get Alert |
05/05/2021 | IONS | Ionis Pharmaceuticals | FY | 2021 | — | — | — | $600.00M | — | $632.68M | Get Alert |
02/24/2021 | IONS | Ionis Pharmaceuticals | FY | 2021 | — | — | — | $600.00M | — | $781.31M | Get Alert |
02/26/2020 | IONS | Ionis Pharmaceuticals | FY | 2020 | — | — | — | $700.00M | — | $814.68M | Get Alert |
11/06/2019 | IONS | Ionis Pharmaceuticals | FY | 2019 | — | — | — | $1.00B | $1.00B | $832.15M | Get Alert |
There have been no specific sales or earnings guidance reported for Ionis Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.